trial · primary record
Icotrokinra
Arthritis, Psoriatic
| Phase | Phase 3 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 813 |
| Primary completion | 2028-10-18 |
| Primary endpoint | Proportion of Participants who Achieved an American College of Rheumatology (ACR) 20 Response at Week 16 |
| Registry ID | NCT06807424 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:47.348Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06807424
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Icotrokinra · compound